• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Counterfeit MabThera Found in Germany

Article

Following Herceptin earlier this year, Roche has announced that tampered vials of it's blood cancer drug MabThera (Rituxan) were found in Germany.

Swiss drugmaker Roche said on Friday that compromised vials of its top-selling blood cancer drug MabThera had been found in Germany, the second time this year that one of its medicines has been targeted by counterfeiters.

MabThera, which is also known as Rituxan, is an injectable biotech drug used to treat blood cancer and rheumatoid arthritis. In 2013 it was Roche's biggest seller with sales of 6.95 billion Swiss francs ($7.45 billion).

"Roche was alerted that counterfeit MabThera was detected in Germany by a German parallel importer," the drugmaker said in an emailed statement.

breast cancer

Earlier this year, vials of Roche's drug Herceptin, thought to be stolen from hospitals in Italy and then tampered with, were found in Britain, Finland and Germany.

Link to the complete article: http://bit.ly/1r0fMtx

Source: Medpage

Related Videos
Mila Felder, MD, FACEP
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance (COA) and physician and partner of AO Multispecialty Clinic in Augusta, Georgia.
Dr Lucy Langer
Edward Arrowsmith, MD, MPH
Dr Kathi Mooney
Tiago Biachi de Castria, MD, PhD, Moffitt Cancer Center
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.